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Abstract 
 
 
 
 
 
 
 
The side effects of Finasteride are currently a subject of controversy. Some studies 
report minor or acceptable adverse effects, which decrease after a variable period of time so 
that they do not necessitate terminating Finasteride administration. However, several clinical 
and neuro-endocrine studies show that some adverse effects persist indefinitely in the form of 
post-Finasteride syndrome, even after the drug cessation.  
This paper presents a possible explanation for these inconsistent findings. First, the 
study design of either informing or not informing patients prior therapy about possible adverse 
effects can influence the incidence and magnitude of reported adverse effects. Second, 
structural and information dichotomies of the brain generate four distinct neuronal networks, 
which are activated through specific cerebral neuromodulators and that are able to support 
four distinct minds within an individual body.  
As a conclusion, the “mind psychophysiology” and the corresponding mental 
impairments differ across individuals, such that not only the prediction of adverse effects 
should be addressed from a more individualized medical perspective, but also the therapeutic 
strategies could be tailored to the four distinct mental profiles described. It is a personalized 
approach that would be applicable to several interrelated domains of neuroscience, like 
psychology, psychiatry and sexuality. Finally, this perspective may represent a starting point 
for a more individualized understanding of mental events, perhaps even a step forward in the 
understanding of the mind-body problem.  
 
Acne conglobata is a rare, severe form of acne vulgaris characterized by the presence of comedones, 
papules, pustules, nodules and sometimes hematic or meliceric crusts, located on the face, trunk, neck, arms 
and buttocks.  
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Introduction 
Finasteride (a 5-α reductase inhibitor) is currently an 
extensively-used medication for two distinct conditions 
strongly related to androgens: male androgenic alopecia 
and benign prostatic hyperplasia. Therapeutic results are 
maintained only as long as the drug is administered, 
most patients losing the medical and/ or aesthetic 
benefits from therapy once the drug is terminated. 
Moreover, during the therapeutic phase, some patients 
report variable adverse effects which either diminish 
during or after therapy in some patients (1), or persist 
indefinitely in others in the form of post-finasteride 
syndrome (2).     
The most frequent manifestations of post-finasteride 
syndrome are represented by sexual disorders and 
mental/ psychological impairments. Interestingly, 
cognition and sexuality show several interrelations 
which become apparent not only during normal 
functioning but also during disease states. Both 
cognition and sexuality, for example, depend on the 
same set of environmental stimuli and centrally are 
presumably supported by a common/ mental operator, 
namely the attentional focus. The existing 
psychophysiologic/ neuroendocrine interrelations 
between cognition and sexuality are bidirectional —
cognition affecting sexual response and vice versa— and 
to a large extent are responsible for the persistence of 
Finasteride adverse effects after treatment cessation (3).  
Even though some data suggest that Finasteride side 
effects (occurring during the drug administration) should 
be differentiated from post-finasteride syndrome 
(registered after treatment cessation) (4), they are 
relatively similar and both are characterized by mental 
impairment (anhedonia, depression, lack of mental 
concentration, suicidal ideations, etc.) and sexual 
disorders (decreased libido, impotence/ erectile 
dysfunction, ejaculation disorders, etc.). Other adverse 
effects include gynecomastia, secondary infertility, 
chronic fatigue, increased fat deposition, etc (3-5).  
Based on previous reports, finasteride appears to 
decrease sexual function predominantly in right handed 
men, while tamoxifen—an estrogen modulator—induces 
adverse reactions especially in left-handed men (6, 7). 
These different effects appear to result from a lateralized 
neurosteroid activation process in the brain. As a 
consequence, finasteride adverse effects could be 
predicted based on this structural dichotomy of the brain, 
using such lateralized functions as hand preference and 
sexual orientation as pretreatment delineating elements 
(8, 9). Beyond this structural dichotomy, the human 
brain also presents a functional/ informational 
dichotomy, with sexual hormones acting primarily upon 
concrete mental functioning, and sexual pheromones 
modulating abstract mental functioning (10). Thus, 
patients having a strong pheromonal activation of 
sexuality would present a low or minimal risk for 
developing adverse reactions to Finasteride 
administration.  
As a preliminary conclusion, the incidence and 
magnitude of Finasteride side effects depend to a great 
extent on the structural and informational dichotomies of 
the brain (11), which delineate within the brain four 
distinct minds (12, 13). The structural dichotomy was 
partly addressed by our recent report indicating that 
biological parameters such as hand preference and 
sexual orientation are linked to brain lateralization (8, 9). 
The informational dichotomy will be investigated in the 
near future using specific psychological tests/ tools that 
enable differentiation between abstract and concrete 
mental functioning.  
This paper presents the most relevant findings 
regarding the distribution of Finasteride side effects 
among patients, and argues for the necessity to adopt an 
individualized approach to the administration of 
Finasteride in male androgenic alopecia and benign 
prostatic hyperplasia.  
 
Discussion 
Concerns related to Finasteride side effects 
Five years ago, a study performed on thirty-three 
men (with right-handed participants having lower overall 
IIEF scores than left-handed participants) found that left-
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handed men showed better post-treatment scores than 
right-handed men on IIEF-assessed sexual functioning 
following Finasteride administration. Interaction effects 
were found on five subscales—erectile function (EF), 
intercourse satisfaction (IS), orgasmic function (OF), 
sexual desire (SD), and overall satisfaction (OS)—such 
that left-handed men showed increased post-treatment 
scores whereas right-handed men showed decreased 
post-treatment scores (6). Two years later, a pilot study 
revealed that administration of Tamoxifen for male 
breast cancer induced sexual side effects especially in 
left handed participants. Thus, a main effect for 
tamoxifen was found on all five subscales, with 
tamoxifen decreasing sexual functioning in both groups 
of men. Interaction effects were found on three IIEF 
subscales (OF, SD, and OS), such that left-handed men 
showed greater decreased sexual function under 
tamoxifen than right-handed men (7).  
Studies related to finasteride have shown that the 
frequency and magnitude of adverse effects are higher 
when patients are informed about possible adverse 
effects and lower or absent (even ignored) when not 
informed (14). As a consequence, the reported adverse 
effects depend on multiple subjective and objective 
factors, including study design, the structural dichotomy 
of the brain (lateralization), and the informational 
dichotomy of the brain. Not surprisingly, recent reports 
have advanced the idea that hand preference and sexual 
orientation (both strongly related to brain lateralization) 
might be used as possible predictors for finasteride 
adverse effects in male androgenic alopecia (8, 9). Other 
data suggest that beyond just predictability, hand 
preference and sexual orientation might also be used for 
therapeutic guidance on Finasteride administration, 
taking into account both structural and informational 
dichotomies of the brain (11). 
Increasing concern for the predictability and 
management of Finasteride side effects is justified by the 
severity of some of its adverse events (2). Thus, recent 
data indicate that androgenic alopecia and benign 
prostatic hyperplasia can lead to depressive symptoms 
and suicidal thoughts among former finasteride users 
who develop persistent sexual side effects (15-18). 
These side effects are yet under evaluation, a relatively 
difficult process due to the fact that the pathophysiology 
of mental and sexual functions (often affected in 
tandem) are not fully documented. Moreover, the post-
finasteride syndrome is only recently recognized as a 
distinct clinical entity, requiring further study with 
respect to the psycho-neuroendocrine processes involved 
(3, 4). 
In support of this, a very recent study has shown that 
some patients treated with finasteride for male pattern 
hair loss develop post-finasteride syndrome, in the form 
of persistent sexual side effects, anxiety, depression, and 
cognitive impairments. These persistent effects are 
associated with changes in steroid levels in cerebrospinal 
fluid, represented by decreased levels of pregnenolone, 
progesterone, dihydroprogesterone, dihydrotestosterone, 
17beta-estradiol, and increased levels of 
dehydroepiandrosterone, testosterone and 5alpha-
androstane-3alpha,17beta-diol (19). These neuro-
endocrine abnormalities are complicated by the finding 
that many former users of finasteride experience 
decreased alcohol tolerance due to cerebral interference 
of Finasteride with GABAA receptors (20). 
Even though some finasteride side effects appear 
severe, suggested resolution varies from an extreme 
therapeutic approach (involving replacement of 
Finasteride with the more active compound Dutasteride) 
(21), to an exclusive pharmaco-vigilance perspective 
imposing prudence and drug substitution (18). Other 
authors consider that finasteride should be retained as a 
valid therapeutic approach for androgenic alopecia, due 
to two important reasons (22). First, dihydrotestosterone 
has important physiological roles within the body (23) 
such that partial suppression of this hormone (specific 
for Finasteride) is preferred over complete suppression 
(the case of Dutasteride). In addition, replacement of 
Finasteride with Dutasteride might exacerbate adverse 
effects. Yet, the therapeutic action of Finasteride could 
be enhanced using a synergistic compound, such as 
minoxidil for androgenic alopecia (24). Second, even if 
Finasteride side effects are more frequent or severe than 
Ion G. Motofei et al. 
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initially assumed, these adverse effects could be 
anticipated through a screening of patients on a priori 
criteria (8, 9). To understand these criteria, namely why 
some men respond with severe adverse effects and 
others do not, it is necessary to understand the structural 
and informational dichotomies of the brain.   
Informational dichotomy of the brain  
The classical input system for information coursing 
to the brain is related to the dorsal system of attention, 
with environmental stimuli/data being transmitted to the 
thalamus, the somatic cortex, and, further, the autonomic 
nervous system (ANS). The ANS supports autonomic 
processing of data/information as well as elaboration of 
specific responses, which are externalized in the form of 
motor/ verbal events through the pyramidal motor 
system. From a psychological perspective, this circuit of 
information supports the concrete mind. In parallel with, 
yet mutually exclusive of, this concrete mind is the 
abstract mind, supported by the ventral system of 
attention, receiving therefore data through the ventral 
hypothalamic input route (25). From here information is 
sent first to the autonomic nervous system of the brain 
and subsequently to the somatic nervous system of the 
brain (25, 26). 
Recent data suggest that sexual hormones activate 
the concrete mind, while sexual pheromones activate the 
parallel, mutually exclusive, abstract mind (11, 27). 
Thus persons depending on sexual pheromones for 
activation should be unaffected by antihormonal 
compounds. Due to limited space herein, the psycho-
physiological elements delineating abstract and concrete 
minds are discussed in a forthcoming paper. Various 
psychological tests/assessments should enable 
identification of individuals with a concrete 
psychological profile, specifically those individuals 
having an increased risk for adverse effects to 
finasteride.  
Structural dichotomy of the brain (lateralization) 
The human brain is structurally divided by the 
median plane into two opposite/ symmetric (left and 
right) hemibrains. If data reception is ensured by both 
hemibrains, processing of information occurs usually in 
only one hemibrain (defined as the dominant hemibrain). 
Accordingly, the opposite/ non-dominant hemibrain 
would support only the neurological connection (inputs/ 
outputs) between dominant hemibrain and peripheral 
receptors/ effectors (26). This asymmetric functioning of 
the brain has been demonstrated for multiple cerebral 
functions (hand preference, language, memory, 
affection, sexuality, etc.) and is ensured through the 
intervention of different neuromodulators that direct 
environmental information towards either the left or the 
right hemibrain (26). In the absence of this lateralization, 
the two distinct hemibrains would receive and process 
distinct responses to the same internal (memory/ 
imagination) or external data, a competitive situation 
that would be physiologically and psychologically 
counterproductive due to the possibility of conflicting 
outputs (26, 28). 
Structural and informational dichotomies of the 
brain 
Based on such lateralized functioning, estrogens 
would modulate environmental inputs especially toward 
the right and concrete hemibrain, while androgens would 
channel the same environmental information/ inputs 
toward the left and concrete hemibrain (11). For this 
reason, administration of antiestrogens such as 
Tamoxifen induces sexual impairment especially in left 
handed men, while administration of Finasteride or 
Bicalutamide induces sexual impairment predominantly 
in right handed men (6, 7, 29).  
In a similar lateralized manner, female sexual 
pheromones would activate (in heterosexual men) 
especially the right and abstract hemibrain (right 
hippocampus, right parahippocampal gyrus, etc.). In 
contrast, male sexual pheromones would activate in 
homosexual men predominantly the left and abstract 
hemibrain (the left angular gyrus, left caudate nucleus, 
etc.). Imaging studies show that heterosexual men and 
homosexual women (lesbians) present a rightward 
volumetric cerebral asymmetry (their connections being 
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more widespread from the right amygdala), while 
homosexual men and heterosexual women display more 
widespread connections from the left amygdala (30-34).  
The importance of an individualized approach to the 
administration of Finasteride 
According to previous findings, the “mind 
psychophysiology” and its corresponding mental 
impairments differ across individuals, not only resulting 
in differential adverse effects as described, but also 
suggesting the need for individualized therapeutic 
strategies in the future. This approach might serve as one 
starting point for taking a more individualized approach 
to the understanding of mental events, and furthermore 
may represent a step forward in unraveling the mind-
body problem. 
Specific to the current topic, aggregation of subjects 
(according to specific individual parameters) in groups 
having either predictably high or low risks for specific 
adverse effect might represent one step toward this more 
personalized medical approach. In other words, 
administration of Finasteride should be acceptable to 
those having a low risk for developing adverse effects. 
But those falling into the high risk category for 
finasteride side effects should avoid taking the drug, 
especially given that some adverse effects persist after 
treatment ceases and no specific measures/consensus 
exists for treatment of post-finasteride syndrome.  
 
Conclusions 
Finasteride side effects are generally related to 
several domains of neuroscience, including psychology, 
psychiatry, and sexuality. Unfortunately, such 
disciplines are not yet fully elaborated and integrated, 
such that the reporting of adverse effects induced by 
drugs acting on the brain (interfering with cerebral 
neuromodulators) is not yet standardized.  
Previously we presented in detail the structural (left 
vs. right) and informational (abstract vs. concrete) 
dichotomies of the brain, dividing the brain into four 
distinct neuronal networks able to generate four distinct 
psycho-physiologic profiles (12, 13). These neuronal 
networks are generally incompatible with one another, 
being activated through the intervention of distinct 
(cognitive or sexual) neuromodulators. As a 
consequence, the “mind psychophysiology,” therapeutic 
approach, and possible adverse effects to drugs 
interfering with the brain should be addressed in a more 
individualized manner, taking into account the mind 
(structural/ informational) diversity described in this 
paper.  
Structural diversity was addressed through 
individual elements strongly related to the lateralization 
process of the brain, like hand preference and sexual 
orientation. Informational diversity should become 
quantifiable through specific psychological tools useful 
for patient screening/ allocation to a specific (abstract 
and concrete) mind profile responsive to either sexual 
hormones or pheromones.  
While abstract ideas are able to exert control over 
our biological/physical existence, yet unexplained is the 
manner in which these abstract-immaterial data interfere 
with the material/physical nature of the brain. Several 
Finasteride side effects (depression, low libido, etc.) are 
strongly related to our conscious domain/ attentional 
focus, so a better understanding of these adverse effects 
may inevitably lead to a better understanding of the 
mind psycho-physiology.   
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